
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
SFRP2
Introduction
Secreted frizzled-related protein 2 is a protein that in humans is encoded by the SFRP2 gene.[1][2]
This gene encodes a member of the SFRP family that contains a cysteine-rich domain homologous to the putative Wnt-binding site of Frizzled proteins. SFRPs act as soluble modulators of Wnt signaling. Methylation of this gene is a potential marker for the presence of colorectal cancer.[2]
References
References
- ↑ Melkonyan HS, Chang WC, Shapiro JP, Mahadevappa M, Fitzpatrick PA, Kiefer MC, Tomei LD, Umansky SR (Jan 1998). “SARPs: A family of secreted apoptosis-related proteins”. Proc Natl Acad Sci U S A. 94 (25): 13636–41. doi:10.1073/pnas.94.25.13636. PMC 28358. PMID 9391078.
- ↑ 2.0 2.1 “Entrez Gene: SFRP2 secreted frizzled-related protein 2”.
Further reading
Further reading
- Rattner A, Hsieh JC, Smallwood PM, et al. (1997). “A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors”. Proc. Natl. Acad. Sci. U.S.A. 94 (7): 2859–63. doi:10.1073/pnas.94.7.2859. PMC 20287. PMID 9096311.
- Hu E, Zhu Y, Fredrickson T, et al. (1998). “Tissue restricted expression of two human Frzbs in preadipocytes and pancreas”. Biochem. Biophys. Res. Commun. 247 (2): 287–93. doi:10.1006/bbrc.1998.8784. PMID 9642118.
- Lescher B, Haenig B, Kispert A (1999). “sFRP-2 is a target of the Wnt-4 signaling pathway in the developing metanephric kidney”. Dev. Dyn. 213 (4): 440–51. doi:10.1002/(SICI)1097-0177(199812)213:4<440::AID-AJA9>3.0.CO;2-6. PMID 9853965.
- Chang JT, Esumi N, Moore K, et al. (1999). “Cloning and characterization of a secreted frizzled-related protein that is expressed by the retinal pigment epithelium”. Hum. Mol. Genet. 8 (4): 575–83. doi:10.1093/hmg/8.4.575. PMID 10072424.
- Lee CS, Buttitta LA, May NR, et al. (2000). “SHH-N upregulates Sfrp2 to mediate its competitive interaction with WNT1 and WNT4 in the somitic mesoderm”. Development. 127 (1): 109–18. PMID 10654605.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Clark HF, Gurney AL, Abaya E, et al. (2003). “The Secreted Protein Discovery Initiative (SPDI), a Large-Scale Effort to Identify Novel Human Secreted and Transmembrane Proteins: A Bioinformatics Assessment”. Genome Res. 13 (10): 2265–70. doi:10.1101/gr.1293003. PMC 403697. PMID 12975309.
- Brophy PD, Lang KM, Dressler GR (2004). “The secreted frizzled related protein 2 (SFRP2) gene is a target of the Pax2 transcription factor”. J. Biol. Chem. 278 (52): 52401–5. doi:10.1074/jbc.M305614200. PMID 14561758.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). “Complete sequencing and characterization of 21,243 full-length human cDNAs”. Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Lee JL, Lin CT, Chueh LL, Chang CJ (2004). “Autocrine/paracrine secreted Frizzled-related protein 2 induces cellular resistance to apoptosis: a possible mechanism of mammary tumorigenesis”. J. Biol. Chem. 279 (15): 14602–9. doi:10.1074/jbc.M309008200. PMID 14709558.
- Müller HM, Oberwalder M, Fiegl H, et al. (2004). “Methylation changes in faecal DNA: a marker for colorectal cancer screening?”. Lancet. 363 (9417): 1283–5. doi:10.1016/S0140-6736(04)16002-9. PMID 15094274.
- Brandenberger R, Wei H, Zhang S, et al. (2005). “Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation”. Nat. Biotechnol. 22 (6): 707–16. doi:10.1038/nbt971. PMID 15146197.
- Zhang Z, Henzel WJ (2005). “Signal peptide prediction based on analysis of experimentally verified cleavage sites”. Protein Sci. 13 (10): 2819–24. doi:10.1110/ps.04682504. PMC 2286551. PMID 15340161.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Otsuki T, Ota T, Nishikawa T, et al. (2007). “Signal sequence and keyword trap in silico for selection of full-length human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA libraries”. DNA Res. 12 (2): 117–26. doi:10.1093/dnares/12.2.117. PMID 16303743.
- Clément G, Braunschweig R, Pasquier N, et al. (2006). “Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett’s esophagus”. Oncogene. 25 (21): 3084–92. doi:10.1038/sj.onc.1209338. PMID 16407829.
- Urakami S, Shiina H, Enokida H, et al. (2006). “Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection”. Clin. Cancer Res. 12 (7 Pt 1): 2109–16. doi:10.1158/1078-0432.CCR-05-2468. PMID 16609023.
- Olsen JV, Blagoev B, Gnad F, et al. (2006). “Global, in vivo, and site-specific phosphorylation dynamics in signaling networks”. Cell. 127 (3): 635–48. doi:10.1016/j.cell.2006.09.026. PMID 17081983.
- Huang ZH, Li LH, Yang F, Wang JF (2007). “Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions”. World J. Gastroenterol. 13 (6): 950–4. doi:10.3748/wjg.v13.i6.950. PMID 17352030.
- Veeck J, Noetzel E, Bektas N, Jost E, Hartmann A, Knuchel R, Dahl E (2008). “Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer”. Mol Cancer. 7 (83): 83. doi:10.1186/1476-4598-7-83. PMCÂ 2613402. PMIDÂ 18990230.
